Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, February 10, 2010, 9:46AM ET - U.S. Markets close in 6 hours and 14 minutes. Dow Down 0.20% Nasdaq Down 0.10%
Bio-Rad Laboratories, Inc. (BIO)At 9:30AM ET: 93.10  Down 0.48 (0.51%)  
MORE ON BIO
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules, CA 94547
United States - Map
Phone: 510-724-7000
Fax: 510-741-5815
Web Site: http://www.bio-rad.com

DETAILS 
Index Membership:S&P 400 MidCap
S&P 1500 Super Comp
Sector:Technology
Industry:Scientific & Technical Instruments
Full Time Employees:6,600

BUSINESS SUMMARY 
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company’s products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. This segment serves hospital laboratories, reference laboratories, physician office laboratories, government agencies, and diagnostic manufacturers. The company was founded in 1952 and is headquartered in Hercules, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Bio-Rad Laboratories, Inc.


    CORPORATE GOVERNANCE 
    Bio-Rad Laboratories, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Feb-10 is better than 0.3% of S&P 400 companies and 3.7% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Norman Schwartz , 60
    Chief Exec. Officer, Pres
    $ 1.25M $ 314.00K
    Ms. Christine A. Tsingos , 51
    Chief Financial Officer and VP
    $ 574.00K $ 288.00K
    Mr. Sanford S. Wadler , 63
    VP, Sec. and Gen. Counsel
    $ 545.00K $ 721.00K
    Mr. John Goetz , 60
    VP and Group Mang. of Clinical Diagnostics Group
    $ 769.00K $ 1.28M
    Mr. James R. Stark ,
    Principal Accounting Officer and Corp. Controller
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis